Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549-Reference-Cited by-同舟云学术

Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549

Published:1993-01 Issue:9 Volume:75 Page:811-819
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

Gueddari N.,Favre G.,Hachem H.,Marek E.,Le Gaillard F.,Soula G.

Publisher

Elsevier BV

Subject

General Medicine,Biochemistry

Reference41 articles.

1. Regulation of the mevalonate pathway;Goldstein;Nature,1990

2. Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene;Smith;J Biol Chem,1990

3. Hypocholesterolaemia in malingnancy due to elevated low-density-lipoprotein-receptor activity in tumor cells. Evidence from studies in patients with leukaemia;Vitols;Lancet,1985

4. Uptake of low density lipoproteins by human leukemic cells in vivo: Relation to plasma lipoprotein levels and possible relevance for selective chemotherapy;Vitols,1990

5. Low density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleids in management of gynecologic neoplasms;Gal;Am J Obstet Gynecol,1981

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LRP1 as a promising therapeutic target for gastrointestinal tumors: Inhibiting proliferation, invasion and migration of cancer cells;Oncology Letters;2023-08-22

2. Repurposing of metabolic drugs and mitochondrial modulators as an emerging class of cancer therapeutics with a special focus on breast cancer;Advances in Cancer Biology - Metastasis;2022-12

3. Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor;Cellular Oncology;2022-07-22

4. Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance;International Journal of Molecular Sciences;2022-06-29

5. Repurposing of Metabolic Drugs and Mitochondrial Modulators as an Emerging Class of Cancer Therapeutics with a Special Focus on Breast Cancer;SSRN Electronic Journal;2022